Abstract
Aim:
(−)-Epigallocatechin-3-gallate (EGCG) is one of the most abundant polyphenols in green tea with strong antioxidant activity and various therapeutic effects. In this study, we investigated the anti-fibrotic effects of EGCG and underlying mechanisms in bile duct-ligated (BDL) rats and a liver fibrosis model in vitro.
Methods:
BDL rats were treated with EGCG (25 mg·kg−1·d−1, po) for 14 d, and then the serum, bile and liver samples were collected. Liver fibrosis was assessed by serum, urine and bile biochemistry analyses and morphological studies of liver tissues. TGF-β1-stimulated human hepatic stellate LX-2 cells were used as a liver fibrosis model in vitro. The expression of liver fibrogenic genes and signaling proteins in the PI3K/Akt/Smad pathway was examined using Western blotting and/or real-time PCR.
Results:
In BDL rats, EGCG treatment significantly ameliorates liver necrosis, inflammation and fibrosis, and suppressed expression of the genes associated with liver inflammation and fibrogenesis, including TNF-α, IL-1β, TGF-β1, MMP-9, α-SMA, and COL1A1. In LX-2 cells, application of EGCG (10, 25 μmol/L) dose-dependently suppressed TGF-β1-stimulated expression of COL1A1, MMP-2, MMP-9, TGF-β1, TIMP1, and α-SMA. Furthermore, EGCG significantly suppressed the phosphorylation of Smad2/3 and Akt in the livers of BDL rats and in TGF-β1-stimulated LX-2 cells. Application of LY294002, a specific inhibitor of PI3K, produced similar effects as EGCG did in TGF-β1-stimulated LX-2 cells, but co-application of EGCG and LY294002 did not produce additive effects.
Conclusion:
EGCG exerts anti-fibrotic effects in BDL rats and TGF-β1-stimulated LX-2 cells in vitro via inhibiting the PI3K/Akt/Smad pathway.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Friedman SL . Hepatic fibrosis — overview. Toxicology 2008; 254: 120–9.
Puche JE, Saiman Y, Friedman SL . Hepatic stellate cells and liver fibrosis. Compr Physiol 2013; 3: 1473–92.
Hirschfield GM, Heathcote EJ, Gershwin ME . Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 2010; 139: 1481–96.
Fickert P, Stieger B . Molecular pathogenesis of chronic cholestatic liver disease: Impact on novel therapeutic approaches. Mol Aspects Med 2014; 37: 1–2.
Shanafelt TD, Call TG, Zent CS, Leis JF, LaPlant B, Bowen DA, et al. Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia. Cancer 2013; 119: 363–70.
Singh BN, Shankar S, Srivastava RK . Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011; 82: 1807–21.
Yasuda Y, Shimizu M, Sakai H, Iwasa J, Kubota M, Adachi S, et al. (−)-Epigallocatechin gallate prevents carbon tetrachloride-induced rat hepatic fibrosis by inhibiting the expression of the PDGFRbeta and IGF-1R. Chem Biol Interact 2009; 182: 159–64.
Tipoe GL, Leung TM, Liong EC, Lau TY, Fung ML, Nanji AA . Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology 2010; 273: 45–52.
Xiao J, Ho CT, Liong EC, Nanji AA, Leung TM, Lau TY, et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur J Nutr 2014; 53: 187–99.
Sakata R, Ueno T, Nakamura T, Sakamoto M, Torimura T, Sata M . Green tea polyphenol epigallocatechin-3-gallate inhibits platelet-derived growth factor-induced proliferation of human hepatic stellate cell line LI90. J Hepatol 2004; 40: 52–9.
Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, Enjoji M, et al. Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells. J Lab Clin Med 2005; 145: 316–22.
Nakamuta M, Higashi N, Kohjima M, Fukushima M, Ohta S, Kotoh K, et al. Epigallocatechin-3-gallate, a polyphenol component of green tea, suppresses both collagen production and collagenase activity in hepatic stellate cells. Int J Mol Med 2005; 16: 677–81.
Yumei F, Zhou Y, Zheng S, Chen A . The antifibrogenic effect of (−)-epigallocatechin gallate results from the induction of de novo synthesis of glutathione in passaged rat hepatic stellate cells. Lab Invest 2006; 86: 697–709.
Zhen MC, Huang XH, Wang Q, Sun K, Liu YJ, Li W, et al. Green tea polyphenol epigallocatechin-3-gallate suppresses rat hepatic stellate cell invasion by inhibition of MMP-2 expression and its activation. Acta Pharmacol Sin 2006; 27: 1600–7.
Shim JH, Su ZY, Chae JI, Kim DJ, Zhu F, Ma WY, et al. Epigallocatechin gallate suppresses lung cancer cell growth through Ras-GTPase-activating protein SH3 domain-binding protein 1. Cancer Prev Res (Phila) 2010; 3: 670–9.
He H, Mennone A, Boyer JL, Cai SY . Combination of retinoic acid and ursodeoxycholic acid attenuates liver injury in bile duct-ligated rats and human hepatic cells. Hepatology 2011; 53: 548–57.
Fickert P, Fuchsbichler A, Marschall HU, Wagner M, Zollner G, Krause R, et al. Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. Am J Pathol 2006; 168: 410–22.
Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, Blaner WS, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005; 54: 142–51.
Zhang H, Zhang S, He H, Zhao W, Chen J, Shao RG . GAP161 targets and downregulates G3BP to suppress cell growth and potentiate cisplaitin-mediated cytotoxicity to colon carcinoma HCT116 cells. Cancer Sci 2012; 103: 1848–56.
Maillette de Buy Wenniger L, Beuers U . Bile salts and cholestasis. Dig Liver Dis 2010; 42: 409–18.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81170409, 81101720), the National S&T Major Special Project on Major New Drug Innovation (2012ZX09301002-001), the Wang Bao En Liver Fibrosis Foundation (20110026), and the Sichuan Provincial People's Hospital Doctor's Foundation (30305030828).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yu, Dk., Zhang, Cx., Zhao, Ss. et al. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway. Acta Pharmacol Sin 36, 473–482 (2015). https://doi.org/10.1038/aps.2014.155
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2014.155
Keywords
This article is cited by
-
Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
BMC Gastroenterology (2018)
-
D-chiro-inositol effectively attenuates cholestasis in bile duct ligated rats by improving bile acid secretion and attenuating oxidative stress
Acta Pharmacologica Sinica (2018)
-
Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways
Scientific Reports (2017)
-
Unconjugated bilirubin elevation impairs the function and expression of breast cancer resistance protein (BCRP) at the blood-brain barrier in bile duct-ligated rats
Acta Pharmacologica Sinica (2016)
-
A comprehensive overview of hepatoprotective natural compounds: mechanism of action and clinical perspectives
Archives of Toxicology (2016)
